|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
97,237,000 |
Market
Cap: |
1.94(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.015 - $0.36 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Calithera Biosciences is a clinical-stage precision oncology biopharmaceutical company developing targeted therapies to redefine treatment for biomarker-specific patient populations. Co.'s product candidate, CB-280, is an oral inhibitor of arginase, developed for the treatment of cystic fibrosis. Co. has also identified CB-668, an orally administered inhibitor of the immune-suppressive enzyme IL4I1. An additional arginase inhibitor, INCB001158, was discovered by Co. and is being developed by Incyte Corporation for oncology and hematology indications. Co. has developed CB-708, a selective, orally-bioavailable small molecule inhibitor of CD73.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
121,333 |
Total Sell Value |
$0 |
$0 |
$0 |
$46,810 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bennett Mark K |
SR. VP, RESEARCH |
|
2015-12-29 |
4 |
OE |
$0.48 |
$16,617 |
D/D |
10,413 |
10,413 |
|
- |
|
Molineaux Christopher |
SR. VP, DEVELOPMENT |
|
2015-12-21 |
4 |
OE |
$0.96 |
$17,739 |
D/D |
10,167 |
39,542 |
|
- |
|
Molineaux Susan |
PRESIDENT AND CEO |
|
2015-12-21 |
4 |
OE |
$0.48 |
$41,525 |
D/D |
27,825 |
109,112 |
|
- |
|
Hecht Curtis |
VP, BUS. & CORP. DEVELOPMENT |
|
2015-11-16 |
4 |
AS |
$6.58 |
$6,385 |
D/D |
(970) |
8,625 |
|
- |
|
Gross Phillip |
10% Owner |
|
2015-09-23 |
4 |
B |
$6.07 |
$243,768 |
I/I |
40,168 |
3,135,069 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2015-09-22 |
4 |
B |
$6.00 |
$250,938 |
I/I |
41,800 |
3,094,901 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2015-09-22 |
4 |
B |
$6.00 |
$149,943 |
I/I |
25,000 |
3,053,101 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2015-09-04 |
4 |
B |
$5.95 |
$13,685 |
I/I |
2,300 |
3,028,101 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2015-09-03 |
4 |
B |
$5.93 |
$521,840 |
I/I |
88,000 |
3,025,801 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2015-08-28 |
4 |
B |
$5.55 |
$237,645 |
I/I |
42,700 |
2,937,801 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2015-08-27 |
4 |
B |
$5.17 |
$520,207 |
I/I |
97,168 |
2,895,101 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2015-08-26 |
4 |
B |
$4.65 |
$149,070 |
I/I |
32,058 |
2,797,933 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2015-08-26 |
4 |
B |
$4.70 |
$940 |
I/I |
200 |
2,765,875 |
1.42 |
- |
|
Hecht Curtis |
VP, BUS. & CORP. DEVELOPMENT |
|
2015-08-20 |
4 |
OE |
$2.64 |
$5,280 |
D/D |
2,000 |
8,625 |
|
- |
|
Waddill William D. |
SR. VP & CFO |
|
2015-07-14 |
4 |
OE |
$2.64 |
$34,650 |
D/D |
13,125 |
15,625 |
|
- |
|
Molineaux Susan |
PRESIDENT AND CEO |
|
2015-07-13 |
4 |
OE |
$0.48 |
$109,890 |
D/D |
76,287 |
78,787 |
|
- |
|
Molineaux Christopher |
SR. VP, DEVELOPMENT |
|
2015-07-13 |
4 |
OE |
$0.96 |
$40,684 |
D/D |
24,375 |
26,875 |
|
- |
|
Bennett Mark K |
SR. VP, RESEARCH |
|
2015-07-08 |
4 |
OE |
$0.48 |
$28,174 |
D/D |
18,365 |
19,501 |
|
- |
|
Waddill William D. |
SENIOR VP & CFO |
|
2014-12-16 |
4 |
OE |
$2.64 |
$23,284 |
I/I |
6,797 |
16,172 |
|
- |
|
Gross Phillip |
10% Owner |
|
2014-10-15 |
4 |
B |
$6.80 |
$264,250 |
I/I |
38,000 |
2,765,675 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2014-10-14 |
4 |
B |
$6.99 |
$384,750 |
I/I |
55,000 |
2,727,375 |
1.5 |
- |
|
Gross Phillip |
10% Owner |
|
2014-10-13 |
4 |
B |
$6.94 |
$615,578 |
I/I |
88,700 |
2,672,375 |
1.5 |
- |
|
Atv Associates Viii, L.l.c. |
10% Owner |
|
2014-10-07 |
4 |
B |
$10.00 |
$3,000,000 |
D/D |
300,000 |
2,110,082 |
2.45 |
- |
|
Atv Associates Viii, L.l.c. |
10% Owner |
|
2014-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,810,082 |
1,810,082 |
|
- |
|
Pakianathan Deepika |
Director |
|
2014-10-07 |
4 |
B |
$10.00 |
$5,000,000 |
I/I |
500,000 |
23,464 |
2.25 |
- |
|
141 Records found
|
|
Page 5 of 6 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|